Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

NCT01420523 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

OTHER_GOV

Sponsor class

Conditions

Human Immunodeficiency Virus
Lipohypertrophy

Interventions

DRUG: Raltegravir-Maraviroc

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]